A two-week course of antiviral therapy with interferon beta-1b plus lopinavir-ritonavir and ribavirin, started within 7 days of showing COVID-19 symptoms, is safe and more effective at reducing the duration...

In a viral haemorrhagic disease where up to 40% of people developing it die, it is remarkable that doctors still do not agree whether the only recognized treatment, an antiviral drug called ribavirin,...

By

New Jersey pharmaceutical company, Valeant Pharmaceuticals has announced the recall of one lot of the powdered antiviral drug,  Virazole® (ribavirin powder for solution) due to microbial contamination. Virazole...

By

Quebec-based PENDOPHARM, a division of Pharmascience Inc., today announced Health Canada approval and market availability of IBAVYRTM (ribavirin tablets), the first stand-alone oral ribavirin for the...